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The discovery of the potent broad spectrum antibiotic, thienamycin and its relatives have stimulated considerable interest in the synthesis of carbapenem analogs.1*2) Extensive structural modification studies of thienamycin resulted in the discovery of iV-formimidoyl thienamycin (MK-0787, imipenem)3) which possesses much improved chemical stability and more potent antibacterial activities than thienamycin. However, the great susceptibility of imipenem toward dehydropeptidase-I (DHP-I) results in extensive renal metabolism in man which leads to very low urinary recovery,4) To prevent this metabolic degradation during therapy, cilastatin (MK-0791)5'6) , a substituted aminopropionate inhibitor of DHP-I, was developed to be co-administered with imipenem. In search of carbapenem antibiotics with the broad antibacterial spectrum of imipenem and with greater stability toward DHP-I, we undertook a chemical modification program of the carbapenem molecule, focusing our attention on the C-2 side chain. Chemical modification of the amide side chain at the C-7 position of cephalosporins and introduction of quaternary heterocyclic methyl groups at the C-3 position had led to a number of clinically useful newclass of cephalosporins, e.g. cefsulodin,70 ceftazidime.8) The conceptual operation of incorporating the quaternary heterocyclic side chains of cephalosporins into the C-2 position of the carbapenemmolecules as quaternary heterocyclic alkylthio groups gave rise to a novel class of carbapenem antibiotics 3. This new class of carbapenems retained the broad antibacterial activity of imipenem including the excellent anti-pseudomonal activity, and also showed an improved stabilitv toward hvdrolvsis bv DHP-I. a Determined by serial 2-fold dilution of compoundin Mueller-Hinton agar and inoculation of the agar surface or broth with an appropriately diluted 18~24 hours broth culture. Agar plates and tubes of broth were incubated at 37°C for 17 hours, and the lowest concentration causing inhibition of visible growth was considered to be the MIC. b Pure hog renal dipeptidase was prepared as described.1^Solutions of carbapenem (0.10 him) in buffer (50 him MOPS,pH 7.1) were freshly prepared. The UV/VIS spectrum of a 2.5-ml aliquot was measured and then 0.025 ml 1 m NH20Hwas added to degrade the^S-lactam bond. The spectrum was again measured after 30 minutes at 25°C and again at 5~10 minutes intervals until no further decrease in absorbance was observed. The different spectrum between intact and degraded /3-lactam was used to calculate a /lmax and s. A similar aliquot of carbapenem solution was incubated at 25°C and the rate of change in absorbance at^maxwas determined. Enzymewas then added to give a rate of at least 10~4 absorbance units per second. The rate of enzymatic hydrolysis was corrected for spontaneous hydrolysis and then converted using e to nmol/minute/ml of enzyme. All rates are reported relative to that observed with imipenem. failed under a variety of reaction conditions, the quaternized intermediate 10 was obtained in high yield by addition of one equivalent of AgClO4. Catalytic hydrogenation of 10 over Pd/C and purification of the crude product by a medium pressure C18^Bondapak column (Waters Associates) gave the zwitterionic compoundll as a white amorphous solid. Similarly, compounds 12 and 13 were prepared by the reaction sequence described above. Alternatively, ll could be obtained in one pot reaction by treatment of 7 with (CF3SO2)2O-pyridine at -20°C. Many other carbapenem analogs possessing the C-2 quaternized heterocyclic alkylthio groups were prepared according to the Scheme 2 as exemplified by the synthesis of 16. Treatment of the phosphate 6 with 2-mercaptomethyl pyridine gave the carbapenem 14 which was then quaternized with methyl iodide or methyl trifluoromethanesulfonate to produce the quaternized intermediate 15 in high yield. Similar treatment of 6 with other heterocyclic alkylthiols followed by quaternization and hydrogenolysis produced carbapenems possessing the C-2 quaternized heterocyclic alkylthio groups (Table 1) .
In Vitro Antibacterial Activity and DHP-I Stability The MICof these new carbapenems are shown in Table 1 . The compoundstested were highly active against a wide range of Gram-positive and Gram-negativeorganisms with MICvalues comparable to imipenem. One general trend in this series of compounds is quite clear: The positive charge in the quaternized heterocyclic ring imparts better anti-pseudomonal activity to the compounds when compared to their unquaternized partners. For example, compounds 17 and 20 which possess no positive charge on the C-2 side chain did not show any significant activity against Pseudomonasaeruginosa strains whereas their positively charged partners 16 and 19 did. The excellent antibacterial activity of the sulfonium derivative 13 indicates that effect of the sulfonium positive charge is equivalent to the quaternized nitrogen. Interestingly, the JV-methyl imidazole derivative 22 which contains a more basic nitrogen than the pyridine derivatives showed good anti-pseudomonal activity, suggesting that a more basic functionality on the C-2 side chain provides better anti-pseudomonal activity. In comparison, the activity of compounds 18 and 19 with 24 and 25 seems to indicate that the position of the positive charge plays the important role for the anti-pseudomonal activity.
In contrast, an additional methyl group at various positions on the pyridine ring (compounds 27 and 28) did not show mucheffect. On the other hand, an additional methyl group at the methylene of the C-2 side chain (compound 26) resulted in the significantly reduced anti-pseudomonal activity, thus implying the importance of the steric bulkiness surrounding the C-2 side chain. The quaternized thiazole 21 and imidazole 23 also showed an excellent overall MIC.
Someof the compoundsin this study were also examined for their stability toward DHP-I (Table  1) and their rate of degradation was measured relative to the rate of imipenem. A comparison of compounds 16 with 17 and 19 with 20 clearly indicates that the quaternization of the pyridine ring leads to significantly reduced DHP-I susceptibility. Additional methyl groups at the methylene of the C-2 side chain (26 vs. 19) also seems to lead to more DHP-I stable compounds.* Experimental Melting points were determined on a Fisher-Johns apparatus and are uncorrected. The UV spectra were run in EtOH; IR spectra were recorded on a Beckman5240 spectrophotometer using KBr pellets; NMRspectra were obtained on a Varian HA-100 spectrometer using (CH3)4Si as an internal standard. All solid compounds were characterized by UV, IR, NMRand elemental analysis (C, H, N). Unless stated otherwise, these analyses were within ±0.4% of the theoretical value. A solution of 1.69 g (4.85 mmol) of Jp-nitrobenzyl-6a-[l-(i?)-hydroxyethyl]-3,7-dioxo-l-azabicyclo-(3.2.0)hept-2-ene-2-carboxylate (5) in 20 ml of acetonitrile was cooled at 0°C under a nitrogen atmosphere. A solution of 726 mg (7.18 mmol) of diisopropylethylamine in 2 ml of acetonitrile was added followed by a dropwise addition of 1.51 g (5.60 mmol) of diphenylchlorophosphate in 12 ml of acetonitrile over a period of 3 minutes. The resulting solution was stirred at 0°C for 20 minutes to provide /7-nitrobenzyl-3 -(diphenylphosphoryloxy)-6a-( l -(i?)-hydroxyethyl]-7-oxol -azabicyclo(3.2.0)hept -2 -ene-2-carboxylate (6) . To this solution was added a solution of 726 mg (7.18 mmol) of diisopropylethylamine in 2 ml of acetonitrile followed by a solution of 439 mg (5.63 mmol) of 2-mercaptoethanol in 2 ml of acetonitrile.
The reaction solution was stirred at 0°C for 3 hours, diluted with 200 ml of EtOAc and washed with 200 ml of water, 100 ml of 20% aq H3PO4, and brine. Evaporation of the dried (MgSO4) solution gave a semisolid which was triturated with methylene chloride and filtered to yield 1.2 g (61 % yield) of the title product 7 as a white amorphous solid: XH NMR (DMSO-d6) 
To a solution of4.2 g (10.3 mmol) of7 in 200ml ofTHF, there was added at -40°C 1.3 g (ll.3 mmol) of methanesulfonyl chloride followed by a dropwise addition of 1.26 g (12.4 mmol) of triethylamine in 5 ml of THF. The reaction mixture was stirred for 5 hours at -40°C, then for 2 hours at -30°C under a nitrogen atmosphere and poured into a mixture of EtOAc (700 ml) and 5 % aq phos- 
A solution of 350 mg (0.72 mmol) of the mesylate 8 and 216 mg (1.4 mmol) of sodium iodide in 20 ml of acetone was heated at reflux for 4 hours. Evaporation of the acetone gave a white amorphous solid which was suspended in ether (10 ml) -water (10 ml). Filtration of the white solid and vacuum drying produced 300 mg (80% yield) of the title compound 9 as a white amorphous powder. 
342-(l -Pyridmium
To a solution of 327 mg (0.63 mmol) of the iodide 9 in 20ml of THF there was added at 0°C 100 mg (1.26 mmol) of pyridine followed by a solution of 139 mg (0.67 mmol) of silver perchlorate in 1 ml of THF. The mixture was stirred for 1 hour at 0°C and then for 2 hours at room temp. The solvent was evaporated in vacuo affording compound10 as a slightly yellow gumwhich was digested with 300 mg of Celite to give an amorphous solid. IR (KBr) cm"1 3400, 1770, 1700, 1100. Without any further purification, compound 10 was hydrogenated. Thus, to a suspended mixture of compound 10 in 50ml of ether and 50 ml of THFthere was added a solution of 126 mg (1.26 mmol) of potassium bicarbonate and 110 mg (0.63 mmol) of dibasic potassium phosphate in 50 ml of water. Then, 350 mg of 10%palladium on charcoal was added and the mixture was hydrogenated at 2.8 kg/cm2 on the Parr shaker for 60 minutes. The mixture was filtered and the catalyst was washed with water (2x 10 ml). The combined filtrate and washings were extracted with ether (2x 100 ml) and lyophilized to give a yellow powder. The crude yellow powder was purified on a C18^Bondapak reverse phase column (8 g) (Waters Associates), eluting with water under 0.56 kg/cm2 pressure. Each 15 ml fraction was assayed by high pressure liquid chromatography, and fractions having an UV absorption at XmsiX 300 nm were collected and lyophilized to give 40 mg (19 % yield based on compound 9) of the title product ll as a white amorphous solid: XHNMR (D2O) Anal Calcd for C16H18N2O4Sà"2H2O: C 51. 84, H 5.40, N 7.56. Found: C 50.91, H 5.08, 
These compoundswere prepared as amorphous solids in the same manner as that described in detail for ll in yields of 18 and 23 %, (based on compounds), respectively. 3.0-3.70 (llH, in), 3.95-4.30 (2H, m) ; IR (KBr) cm"1 3400, 1760, 1590; UV^max (EtOH) nm (e) 289 (6, 200 To a solution of 1.0g (1.167mmol) of compound 15 in 90ml of THF and 90ml of ether was added 215 mg (2.15 mmol) of KHCO3 and 374 mg (2.1 mmol) of K2HPO4 in 90 ml of water followed by 1.0 g of 10% palladium on charcoal. The mixture was hydrogenated at 3.2 kg/cm2 on the Parr shaker for 45 minutes. The mixture was filtered through a Celite pad and the catalyst was washed with water (2 x 10 ml). The combined filtrate and washings were extracted with ether (2 x200 ml) and lyophilized to give a yellow solid which was purified on a C18 >Bondapak (Waters Associates) reverse phase column (10 g), eluting with 5 % acetonitrile in water under 0.56 kg/cm2 pressure. Each 15 ml fraction was assayed by high pressure liquid chromatography and fractions having UVabsorption at^max 300 nm were collected and lyophilized to give 390 mg (44% yield) of the title product. Recrystallization of this material from water -acetone -EtOHproduced fine needles: MP194-196°C (dec); *H NMR (D2O) 3 1.30 (3H, d, /=6.2Hz), 3.2 (2H, q, /-9.0 and 3.6Hz), 3.46 (1H, q, /=6.0 and 2.7 Hz), 4.1-4.16 (3H, m), 4.60 (3H, s), 7.9-8.9 (4H, m); IR (KBr) cm"1 3400, 1755, 1590; UV^max (H2O) nm (e) 292 (8,092).
Anal Calcd for C16H18N2O4Sà"2H2O: C 51.87, H 5.44, N 7.56. Found: C 51.37, H 5.69, N 7.37. In a similar manner, 18, 19, 21, 23, 24, 25, 26, 27 
